Developer docs
API playgroundTry for free, no card

Search company profiles

Biomex

Full company profile

uuid000dvto

Namestring
Biomex
Websiteurl
biomex.de
Company typeenum
Private
Founded yearint
1989
Descriptiontext

Biomex is a Germany-based biotechnology company headquartered in Heidelberg that supplies biological research inputs — specifically purified analytes, processed negative plasma, and residual patient samples — to the research market. The company has operated continuously since 1989 and currently maintains a workforce of 51–100 employees, suggesting a stable, mid-sized specialty supplier rather than an early-stage venture. Its product set addresses a narrow but recurring need in academic and commercial life-science laboratories for qualified, controlled human-derived biological materials used in assay development, validation, and other research workflows.

The business operates as a for-profit private company (per firmographic classification), though public/private status and ownership structure could not be independently confirmed from the supplied source content. No pricing model, revenue mechanics, customer logos, distribution channels, or go-to-market specifics were disclosed in the available data; the company website rendered only a loader/verification page, and no substantive commercial disclosures were extracted. Consequently, the revenue model, segmentation, and customer mix are data gaps rather than confirmed attributes.

Operationally, Biomex's longevity and Heidelberg base imply incumbency in a regulated handling environment (biological samples, traceability, biohazard compliance), which functions as a soft qualification barrier for research buyers. However, the input does not include certifications, partnerships, patents, product launches, funding history, M&A activity, or technology stack details, so the assessment of strategic positioning is necessarily limited to what the firmographic profile and product description alone support.

Short descriptiontext

Biomex is a Heidelberg, Germany-based biotechnology company, founded in 1989, that supplies purified analytes, processed negative plasma, and residual patient samples to research laboratories.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHeidelberg, Germany
HQ citystring
Heidelberg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
biological research reagents, purified analytes supply, processed negative plasma, residual patient samples, biotechnology specimens
Industry3 codes
1Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
CodeHLAAAJAIPrimaryYes
2Proteomics & Biomarker Analytical Testing
CodeHLAGADAGPrimaryNo
3Cell-Based & Potency Assays (Bioassays)
CodeHLAGADAHPrimaryNo
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
Biological Research Reagents
No data
Cost components3 values
Supply Chain, Operations, Personnel
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Biomex is a biotechnology company that produces and supplies purified analytes, processed negative plasma, and residual patient samples for use in research. Its output consists of physical biological specimens and processed reagents prepared for laboratory and research buyers in the biotechnology and life sciences sectors.

Differentiator
Functional benefit
Problem solved
Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeDirect peer
Description

Major manufacturer of purified biological reagents, controls, and reference materials for life science research and diagnostics — directly comparable to Biomex's purified analytes and processed plasma offerings.

TypeDirect peer
Description

Specializes in diagnostic reagents, antigens, antibodies, and biological raw materials for IVD manufacturers — closely aligned with Biomex's purified analyte and biological-input focus.

TypeBroad incumbent
Description

Global supplier of analytical reagents, biochemicals, and plasma-derived research products; overlaps Biomex's analyte and plasma SKUs as part of a much broader catalog.

TypeBroad incumbent
Description

Provides biological reagents, plasma products, and residual clinical samples for research through its specialty diagnostics and life sciences segments — a much larger incumbent in the same inputs Biomex supplies.

TypeBroad incumbent
Description

Supplies biological research products and services including diagnostic reagents and specialty research models — comparable in serving life science R&D customers with similar inputs.

TypeDirect peer
Description

Manufactures processed plasma, analyte-spiked materials, and reference reagents for diagnostic and clinical research — a direct counterpart to Biomex's processed negative plasma and purified analytes.

TypeBroad incumbent
Description

Produces in vitro diagnostic substances and biological reagents as part of a broader diagnostics portfolio; relevant comparator for Biomex's diagnostic research materials.

TypeEmerging player
Description

Supplies specialty biological materials and reagents into diagnostics and research markets — comparable in scale and product type to Biomex, with overlap in analyte and plasma-based inputs.

TypeRegional player
Description

Germany-based developer of bioreagents and biological materials for research — a regional peer to Biomex in the same German/European life sciences supply market.

TypeRegional player
Description

German supplier of diagnostic reference materials, control plasma, and biological reagents for HLA and clinical research — comparable regional competitor to Biomex in the German life sciences market.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biomex

Biological Research Reagentsbiomex.de

Biomex is a Heidelberg, Germany-based biotechnology company, founded in 1989, that supplies purified analytes, processed negative plasma, and residual patient samples to research laboratories.

What Biomex does

Biomex is a Germany-based biotechnology company headquartered in Heidelberg that supplies biological research inputs — specifically purified analytes, processed negative plasma, and residual patient samples — to the research market. The company has operated continuously since 1989 and currently maintains a workforce of 51–100 employees, suggesting a stable, mid-sized specialty supplier rather than an early-stage venture. Its product set addresses a narrow but recurring need in academic and commercial life-science laboratories for qualified, controlled human-derived biological materials used in assay development, validation, and other research workflows.

The business operates as a for-profit private company (per firmographic classification), though public/private status and ownership structure could not be independently confirmed from the supplied source content. No pricing model, revenue mechanics, customer logos, distribution channels, or go-to-market specifics were disclosed in the available data; the company website rendered only a loader/verification page, and no substantive commercial disclosures were extracted. Consequently, the revenue model, segmentation, and customer mix are data gaps rather than confirmed attributes.

Operationally, Biomex's longevity and Heidelberg base imply incumbency in a regulated handling environment (biological samples, traceability, biohazard compliance), which functions as a soft qualification barrier for research buyers. However, the input does not include certifications, partnerships, patents, product launches, funding history, M&A activity, or technology stack details, so the assessment of strategic positioning is necessarily limited to what the firmographic profile and product description alone support.

Biomex firmographics

Firmographics
Name
Biomex
Website
https://biomex.de
Company type
Private
Founded year
1989
Operating status
Operating
Headcount range
51–100 employees
Short description
Biomex is a Heidelberg, Germany-based biotechnology company, founded in 1989, that supplies purified analytes, processed negative plasma, and residual patient samples to research laboratories.
Ownership category
akta.pro rank

Biomex industry classification

Industry
Product category
Biological Research Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI)
akta.pro secondary industries
Proteomics & Biomarker Analytical Testing (HLAGADAG), Cell-Based & Potency Assays (Bioassays) (HLAGADAH)

Keywords

  • Biological research reagents
  • Purified analytes supply
  • Processed negative plasma
  • Residual patient samples
  • Biotechnology specimens

Where Biomex is headquartered

Location

Headquarters

HQ city
Heidelberg
HQ country
Germany
HQ region
Europe

Markets served

Biomex business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel

Biomex product offering

Product offering

Core offering

Biomex is a biotechnology company that produces and supplies purified analytes, processed negative plasma, and residual patient samples for use in research. Its output consists of physical biological specimens and processed reagents prepared for laboratory and research buyers in the biotechnology and life sciences sectors.

Differentiator

Problem solved

Functional benefit

Companies that use Biomex

Customer profile

Ideal customer profiles1 record

Biomex technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Biomex partnerships and signals

Strategic signal

Recent moves1 record

Biomex competitors and assessment

Company assessment

Direct peers

  • Bio-Rad Laboratories: Major manufacturer of purified biological reagents, controls, and reference materials for life science research and diagnostics — directly comparable to Biomex's purified analytes and processed plasma offerings.
  • BBI Solutions: Specializes in diagnostic reagents, antigens, antibodies, and biological raw materials for IVD manufacturers — closely aligned with Biomex's purified analyte and biological-input focus.
  • SeraCare (LGC Clinical Diagnostics): Manufactures processed plasma, analyte-spiked materials, and reference reagents for diagnostic and clinical research — a direct counterpart to Biomex's processed negative plasma and purified analytes.

Broad incumbents

  • Merck (Sigma-Aldrich): Global supplier of analytical reagents, biochemicals, and plasma-derived research products; overlaps Biomex's analyte and plasma SKUs as part of a much broader catalog.
  • Thermo Fisher Scientific: Provides biological reagents, plasma products, and residual clinical samples for research through its specialty diagnostics and life sciences segments — a much larger incumbent in the same inputs Biomex supplies.
  • Charles River Laboratories: Supplies biological research products and services including diagnostic reagents and specialty research models — comparable in serving life science R&D customers with similar inputs.
  • Roche Diagnostics: Produces in vitro diagnostic substances and biological reagents as part of a broader diagnostics portfolio; relevant comparator for Biomex's diagnostic research materials.

Emerging players

  • Surmodics: Supplies specialty biological materials and reagents into diagnostics and research markets — comparable in scale and product type to Biomex, with overlap in analyte and plasma-based inputs.

Regional players

  • Trina Bioreactives: Germany-based developer of bioreagents and biological materials for research — a regional peer to Biomex in the same German/European life sciences supply market.
  • Inno-Train Diagnostik: German supplier of diagnostic reference materials, control plasma, and biological reagents for HLA and clinical research — comparable regional competitor to Biomex in the German life sciences market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

Biomex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biomex leadership team

Management profile

Number of profiles

Biomex funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biomex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomex

What does Biomex do?

Biomex is a biotechnology company that produces and supplies purified analytes, processed negative plasma, and residual patient samples for use in research. Its output consists of physical biological specimens and processed reagents prepared for laboratory and research buyers in the biotechnology and life sciences sectors.

Is Biomex a public or private company?

Biomex is a private company. It is classified as unknown and is currently operating.

When was Biomex founded?

Biomex was founded in 1989. It employs 51 to 100 people.

Where is Biomex based?

Biomex is headquartered in Heidelberg, Germany, in the Europe region.

Who are Biomex's main competitors?

Direct peers on record are Bio-Rad Laboratories, BBI Solutions and SeraCare (LGC Clinical Diagnostics). Broad incumbents are Merck (Sigma-Aldrich), Thermo Fisher Scientific, Charles River Laboratories and Roche Diagnostics. Surmodics is listed as an emerging player. Regional players are Trina Bioreactives and Inno-Train Diagnostik.

Does Biomex have an API?

No public API is recorded for Biomex.

What industry is Biomex in?

Biomex's product category is Biological Research Reagents. Its primary akta.pro industry code is HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers), with a secondary code of HLAGADAG, Proteomics & Biomarker Analytical Testing. Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales